autologous skin fibroblasts
Cell therapyexperimental
Clinical trial activity
4 trials · 9 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2014 (NCT01964859)
Timeline
Indications
Mechanism of action
- Unspecified targetTissue restoration
Tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- autologous skin fibroblasts
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04818203 | Phase 1/Phase 2 (Phase 2) | Jul 20, 2020 | Dt&Sanomedics, S.Biomedics Co., Ltd. |
| NCT03947450 | Phase 2 | Aug 31, 2019 | Johns Hopkins University |
| NCT04485962 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2017 | Belarusian Medical Academy of Post-Graduate Education, Belarusian State Medical University, National Academy of Sciences of Belarus |
| NCT01964859 | Phase 1 | Dec 1, 2014 | Department of Defense, Johns Hopkins University, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH) |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (9)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Johns Hopkins University | Academic/Hospital | 2 | 2 | 2 | 2014 |
| Belarusian Medical Academy of Post-Graduate Education | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Belarusian State Medical University | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Department of Defense | Government | 1 | 0 | 1 | 2014 |
| Dt&Sanomedics | For profit | 1 | 0 | 1 | 2020 |
| National Academy of Sciences of Belarus | Academic/Hospital | 1 | 1 | 1 | 2017 |
| National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Government | 1 | 0 | 1 | 2014 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 2014 |
| S.Biomedics Co., Ltd. | For profit | 1 | 1 | 1 | 2020 |
9 organizations
Page 1 / 1